Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells

Cancer stem cells (CSCs) are an important therapeutic target. The therapeutic agents targeting CSCs should lead to improved clinical outcomes. Here we have demonstrated the CSC-suppressing activity of pongol methyl ether (PME), a pure compound from <i>Millettia erythrocalyx</i>. Methods:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Arnon Silapech, Satapat Racha, Nithikoon Aksorn, Pennapa Lafauy, Sucharat Tungsukruthai, Chanida Vinayanuwattikun, Boonchoo Sritularak, Pithi Chanvorachote
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Akt
R
Acceso en línea:https://doaj.org/article/520888d5add6491db8b0e70d547c7c33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:520888d5add6491db8b0e70d547c7c33
record_format dspace
spelling oai:doaj.org-article:520888d5add6491db8b0e70d547c7c332021-11-25T18:39:13ZPongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells10.3390/ph141110851424-8247https://doaj.org/article/520888d5add6491db8b0e70d547c7c332021-10-01T00:00:00Zhttps://www.mdpi.com/1424-8247/14/11/1085https://doaj.org/toc/1424-8247Cancer stem cells (CSCs) are an important therapeutic target. The therapeutic agents targeting CSCs should lead to improved clinical outcomes. Here we have demonstrated the CSC-suppressing activity of pongol methyl ether (PME), a pure compound from <i>Millettia erythrocalyx</i>. Methods: CSC-suppressing effects were evaluated by spheroid formation assay and detection of CSC markers. The related CSC cell signals were evaluated by Western blot, immunofluorescence and molecular docking analysis. Proteins affected by PME treatment were subjected to bioinformatic analysis. Protein–protein interaction (PPI) networks were constructed by the Search Tool for Interactions of Chemicals (STITCH). The Kyoto Encyclopedia of Genes and Genomes (KEGG) mapper were used to confirm the underlying pathways. Results: PME (5–25 µM) significantly suppressed the ability of lung cancer cells to form colonies, grow in an anchorage-independent manner and generate tumour spheroids. PME at 25 µM significantly decreased the CSC markers (CD133 and ALDH1A1) and pluripotent transcription factors (Oct4 and Nanog). Akt, the key upstream signal of CSC control, was significantly decreased by the PME treatment. The molecular docking indicated that PME was bound to Akt-1 with a binding affinity of −9.2 kcal/mol greater than the Akt-1 inhibitor (reference compound; CQW). The STITCH network identified a total of 15 proteins interacted in PPI networks, and Akt-1 was identified as a central protein. The KEGG mapper indicated that the selected CSC markers were mostly involved in the ‘signalling pathways regulating pluripotency of stem cells’ pathway map and Akt, Oct4 and Nanog were the regulatory proteins in the dominant pathway. In addition, PME (10–25 µM) can suppress spheroid formation and reduce CSC-specific marker expression in patient-derived primary lung cancer cells. Conclusions: Our study revealed a novel pharmacological effect and the underlying mechanism of PME that can attenuate CSC phenotypes in lung cancer cells and may be developed for lung cancer therapy.Arnon SilapechSatapat RachaNithikoon AksornPennapa LafauySucharat TungsukruthaiChanida VinayanuwattikunBoonchoo SritularakPithi ChanvorachoteMDPI AGarticlepongol methyl ethercancer stem celllung cancerAktCSC-targetingMedicineRPharmacy and materia medicaRS1-441ENPharmaceuticals, Vol 14, Iss 1085, p 1085 (2021)
institution DOAJ
collection DOAJ
language EN
topic pongol methyl ether
cancer stem cell
lung cancer
Akt
CSC-targeting
Medicine
R
Pharmacy and materia medica
RS1-441
spellingShingle pongol methyl ether
cancer stem cell
lung cancer
Akt
CSC-targeting
Medicine
R
Pharmacy and materia medica
RS1-441
Arnon Silapech
Satapat Racha
Nithikoon Aksorn
Pennapa Lafauy
Sucharat Tungsukruthai
Chanida Vinayanuwattikun
Boonchoo Sritularak
Pithi Chanvorachote
Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
description Cancer stem cells (CSCs) are an important therapeutic target. The therapeutic agents targeting CSCs should lead to improved clinical outcomes. Here we have demonstrated the CSC-suppressing activity of pongol methyl ether (PME), a pure compound from <i>Millettia erythrocalyx</i>. Methods: CSC-suppressing effects were evaluated by spheroid formation assay and detection of CSC markers. The related CSC cell signals were evaluated by Western blot, immunofluorescence and molecular docking analysis. Proteins affected by PME treatment were subjected to bioinformatic analysis. Protein–protein interaction (PPI) networks were constructed by the Search Tool for Interactions of Chemicals (STITCH). The Kyoto Encyclopedia of Genes and Genomes (KEGG) mapper were used to confirm the underlying pathways. Results: PME (5–25 µM) significantly suppressed the ability of lung cancer cells to form colonies, grow in an anchorage-independent manner and generate tumour spheroids. PME at 25 µM significantly decreased the CSC markers (CD133 and ALDH1A1) and pluripotent transcription factors (Oct4 and Nanog). Akt, the key upstream signal of CSC control, was significantly decreased by the PME treatment. The molecular docking indicated that PME was bound to Akt-1 with a binding affinity of −9.2 kcal/mol greater than the Akt-1 inhibitor (reference compound; CQW). The STITCH network identified a total of 15 proteins interacted in PPI networks, and Akt-1 was identified as a central protein. The KEGG mapper indicated that the selected CSC markers were mostly involved in the ‘signalling pathways regulating pluripotency of stem cells’ pathway map and Akt, Oct4 and Nanog were the regulatory proteins in the dominant pathway. In addition, PME (10–25 µM) can suppress spheroid formation and reduce CSC-specific marker expression in patient-derived primary lung cancer cells. Conclusions: Our study revealed a novel pharmacological effect and the underlying mechanism of PME that can attenuate CSC phenotypes in lung cancer cells and may be developed for lung cancer therapy.
format article
author Arnon Silapech
Satapat Racha
Nithikoon Aksorn
Pennapa Lafauy
Sucharat Tungsukruthai
Chanida Vinayanuwattikun
Boonchoo Sritularak
Pithi Chanvorachote
author_facet Arnon Silapech
Satapat Racha
Nithikoon Aksorn
Pennapa Lafauy
Sucharat Tungsukruthai
Chanida Vinayanuwattikun
Boonchoo Sritularak
Pithi Chanvorachote
author_sort Arnon Silapech
title Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
title_short Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
title_full Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
title_fullStr Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
title_full_unstemmed Pongol Methyl Ether Inhibits Akt and Suppresses Cancer Stem Cell Phenotypes in Lung Cancer Cells
title_sort pongol methyl ether inhibits akt and suppresses cancer stem cell phenotypes in lung cancer cells
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/520888d5add6491db8b0e70d547c7c33
work_keys_str_mv AT arnonsilapech pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT satapatracha pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT nithikoonaksorn pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT pennapalafauy pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT sucharattungsukruthai pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT chanidavinayanuwattikun pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT boonchoosritularak pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
AT pithichanvorachote pongolmethyletherinhibitsaktandsuppressescancerstemcellphenotypesinlungcancercells
_version_ 1718410833452597248